Hyacinths Pharma Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 02-05-2024
- Paid Up Capital ₹ 32.50 Cr
as on 02-05-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2019)
- Profit -4470.64%
(FY 2019)
- Ebitda -4534.34%
(FY 2019)
- Net Worth 116.93%
(FY 2019)
- Total Assets 126.75%
(FY 2019)
About Hyacinths Pharma
- CIN/LLPIN
U24232TG2010PTC069638
- Company No.
069638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2010
- Date of AGM
24 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyacinths Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Gonugunta | Company Secretary | 23-May-2019 | Current |
Venkata Musunuri  | CFO | 23-May-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Kambam | Director | 16-Sep-2013 | Current |
| Satyanarayana Karri | Whole-Time Director | 23-May-2019 | Current |
| Venkateswararao Kondreddy | Director | 18-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of Hyacinths Pharma.
Hyacinths Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4470.64% decrease in profit. The company's net worth Soared by an impressive increase of 116.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyacinths Pharma?
In 2018, Hyacinths Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Raidurgam Developers LimitedActive 12 years 5 months
Nityananda Kambam and Venkateswararao Kondreddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hyacinths Pharma?
Hyacinths Pharma has a workforce of 23 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyacinths Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyacinths Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
